Indoco Remedies Ltd. Stock price: Live updates

₹247.45

-1.77% (-4.46)

Market Cap

₹2,277 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

2,277 Cr

Prom Holding

58.86 %

ROE (%)

ROCE (%)

-0.56

Div Yield (%)

0.08

Sales

1,843 Cr

OPM (%)

7.69 %

Debt to Equity

0.96

Institutions

19.09 %

Individual < 2 lac

11.52 %

No. of Shareholders

32,276

Edit Ratio's

About

Indoco Remedies Limited is a Public Limited Company domiciled in India and incorporated under … Read more

Low

162

52W Range

High

341

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Share price

Share price has increased over last 10 years due to earnings
Balance Sheet Strength

Balance sheet of the company is moderately strong
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Debt

Company might have issues servicing its debt
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Market Share

0.24 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.99 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.60 %

(as of Nov 21)

Historic

Blood Related - Market Share

0.02 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

10 %

(as of Mar 25)

Source/Historic

Carmicide - Market Share

46 %

(as of Mar 25)

Source/Historic

Cyclopam - Market Share

0.36 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.82 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.24 %

(as of Nov 21)

Historic

Gynecology - Market Share

82 %

(as of Mar 25)

Source/Historic

Homide - Market Share

65.60 %

(as of Mar 23)

Source/Historic

Karvol Plus - Market Share

63.20 %

(as of Mar 23)

Source/Historic

Kidodent - Market Share

2.12 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

0.30 %

(as of Nov 21)

Historic

Pain - Market Share

0.60 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

25 %

(as of Mar 25)

Source/Historic

Renolen - Market Share

1.50 %

(as of Nov 21)

Historic

Respiratory - Market Share

25 %

(as of Mar 25)

Source/Historic

Rexidin M - Market Share

55.50 %

(as of Mar 21)

Source/Historic

Rexidin Plus - Market Share

75 %

(as of Mar 25)

Source/Historic

Sensodent-K - Market Share

15 %

(as of Mar 25)

Source/Historic

Sensodent-KF - Market Share

52 %

(as of Mar 25)

Source/Historic

Sensoform - Market Share

100 %

(as of Mar 23)

Source/Historic

Snowdent - Market Share

23.05 %

(as of Nov 21)

Historic

Stomatological - Market Share

2.45 %

(as of Nov 21)

Historic

Urology - Market Share

0.58 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Formulation

Location Wise Break-Up

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
US DMF Filings (.)
Source
Global DMFs filed (.)
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

IOL Chemicals And Pharmaceuticals Ltd.
Aarti Drugs Ltd.
Kilitch Drugs (India) Ltd.

FAQs on Indoco Remedies Ltd. Business

What does Indoco Remedies do?

Indoco Remedies Limited, based in India, specializes in manufacturing and marketing Formulations and Active Pharmaceutical Ingredients for domestic and international markets.

Who are the competitors of Indoco Remedies?

Indoco Remedies major competitors are Venus Remedies, Sakar Healthcare, Beta Drugs, Ind-Swift Labs., Kwality Pharma, Fredun Pharma, Jagsonpal Pharma.
Market Cap of Indoco Remedies is ₹2,328 Crs.
While the median market cap of its peers are ₹2,034 Crs.

Is Indoco Remedies financially stable compared to its competitors?

Indoco Remedies seems to be less financially stable compared to its competitors.
Altman Z score of Indoco Remedies is 2.13 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Monopoly Companies

Companies which are dominant in a product, usually having a strong moat.

Run Query

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jul Nov	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Feb Jun Sep Dec	Dec		Mar Jun Sep Dec	Mar Jun	Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Feb	Nov	Mar Sep							Mar		Jun	Mar	Dec	Mar
Conference Call	Feb May	Mar Jun Nov	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Claude

Discussions & Analysis

Indoco Remedies Ltd.

Indoco Remedies - Cheapest Domestic Pharma stock or value trap ? - Cash Cow

Detailed Analysis on the business of Indoco Remedies - Value Educator

Business Analysis - A thread on Indoco Remedies - Value Educator

One Hidden Stock in the Pharma Sector! Growing Really Fast - SOIC

Why Indoco Remedies looks Interesting and why FY22-24 growth is likely to be stellar here? - SOIC

View the discussion on ValuePickr

Pharmaceuticals

GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Nutraceuticals- Industry Overview - Value Educator

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Pharma Compliance In-Depth - Amit Rajan

Deep Dive into Pharma Sector - Omkara Capital

How The Pharma Industry Works - PPFAS

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Indoco Remedies Ltd.

Indoco Remedies Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

5 Yes

2 Neutral

9 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Promoter Holding

Retail Holding

Revenue Recognition

Price & Performance

Share price

Balance Sheet Strength

Capex vs ROCE

Current vs Historic Valuation

Debt

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Market Share

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Wise Break-Up - Domestic

UNLOCK PREMIUM

Location Wise Break-Up - Formulation

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Operational Metrics

Peer Comparison

Corporate Actions

Suppliers

FAQs on Indoco Remedies Ltd. Business

What does Indoco Remedies do?

Who are the competitors of Indoco Remedies?

Is Indoco Remedies financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE